There are 2949 resources available
304P - ESR1 mutations and outcomes in BRCA1/2 or PALB2 germline mutation carriers receiving first line aromatase inhibitor + palbociclib (AI+P) for metastatic breast cancer (MBC) in the PADA-1 trial
Presenter: Jean-Sebastien Frenel
Session: E-Poster Display
Resources:
Abstract
306P - Real-life management and prognosis of young women (≤ 40 yo) with de novo metastatic breast cancer in the multicenter national observational ESME program
Presenter: Amélie Francois
Session: E-Poster Display
Resources:
Abstract
307P - Real-world evidence of CDK4/6 Inhibitor combination effects on assessing outcome with different sequence of treatment among adult patients with HR + and HER2 - metastatic breast cancer
Presenter: Silvia Comis
Session: E-Poster Display
Resources:
Abstract
308P - Real-world outcomes among HER2+ metastatic breast cancer patients with brain metastases
Presenter: Nicolas Lindegger
Session: E-Poster Display
Resources:
Abstract
309P - Real-world effectiveness of alpelisib (ALP) + fulvestrant (FUL) compared with standard treatment among patients (Pts) with hormone-receptor positive (HR+) human epidermal growth factor receptor-2 negative (HER2–) PIK3CA-mutated (Mut) advanced breast cancer (ABC)
Presenter: Stuart Turner
Session: E-Poster Display
Resources:
Abstract
310P - Overall survival with cyclin-dependent kinase 4/6 inhibitors plus endocrine therapy in breast cancer: A meta-analysis of randomized controlled trials
Presenter: Qi Tian
Session: E-Poster Display
Resources:
Abstract
311P - Pooled-analysis of prospective observational studies evaluated the effectiveness and safety of bevacizumab and paclitaxel as the first-line chemotherapy for HER2-negative metastatic breast cancer
Presenter: Hiroyasu Yamashiro
Session: E-Poster Display
Resources:
Abstract
312P - Real-world (RW) multi-country study of BRCA1/2 mutation (BRCA1/2mut) testing trends among adult patients (pts) with HER2− advanced breast cancer (ABC)
Presenter: Reshma Mahtani
Session: E-Poster Display
Resources:
Abstract
313P - Real-world multi-country study of treatment trends among patients (pts) with HER2− BRCA1/2 mutated (BRCA1/2mut) advanced breast cancer (ABC)
Presenter: Reshma Mahtani
Session: E-Poster Display
Resources:
Abstract
315P - Trends in breast cancer mortality between 2001 and 2017: An observational study in EU and UK
Presenter: Chinmay Jani
Session: E-Poster Display
Resources:
Abstract